Neurodegenerative disorders

Dystonia is a disorder that affects more than 300,000 people in the United States. It’s a complex disorder that involves varied neurological movement and involuntary muscle contractions. Unfortunately, dystonia isn’t just subjected to people of a certain age or race which means it can affect just about anyone. The good news is that it isn’t as life threatening as many other disorders, but it can seriously impact someone’s life by making it hard to partake in simple daily functions. This disorder causes

Introduction Schizophrenia is a psychiatric disorder that affects about 1% of the adult population and carries a high disease burden involving a number of health comorbidities and an average decrease in life expectancy by 12-15 years. Current drug treatments for schizophrenia primarily target the positive symptoms such as hallucinations and delusions, but usually fail to treat negative symptoms such as social withdrawal, difficulty focusing, and lack of motivation. A major research challenge is to

Alzheimer's disease (AD) is a neurodegenerative disorder with relentlessly progressive losses in cognition, memory, and language. According to research by Herbert, Weuve, Sherr, and Evans (2013), 5.3 million people are affected by AD, and that number is expected to almost triple by the middle of the century. As cognitive decline progresses, independence and the ability to perform self-care is lost as caregivers must assume this considerable burden. Given the prevalence of AD, its devastating pathology

p. 65). This particular disease was chosen due to its severity, swiftness with which it ends life, and its ability to exist undetected without symptoms for decades unless one’s family history is known. Fatal Familial Insomnia, (FFI), is a neurodegenerative prion disease classified as a Transmissible Spongiform Encephalopathy, (TSE), meaning that it is genetically transmitted (Belay, 1999, p. 284). FFI is autosomal dominant (Xie et al., 2013, p81-90), meaning that an individual with A or AA alleles

individual has a diagnosis of Alzheimer’s disease (AD), one can assume that individual may also have a diagnosis with a depressive disorder. Depression in many cases can be the first sign of a neurodegenerative disorder (Yun, 2015, as cited by Green, Cupples, Kurz, Chui, Edeki…Farrer, 2003). Many individuals, who have a neurological disorder, may also develop depressive disorders early on before the appearance of cognitive impairments. Prior research has supported the idea that individuals who are depressed

Multiple sclerosis (MS) is one of the most common neurological disorders constantly leading to perpetual disability in young adults. Accounting for more than 40,000 affected individuals in Egypt alone (Tallawy et al., 2016), and 2.5 million patients worldwide. (MS) is a chronic inflammatory, demyelinating, autoimmune neurodegenerative disease characterized by the disruption of the blood brain barrier (BBB), perivascular inflammation, axonal and oligodendrocyte injury, and breakdown of the myelin

Huntington’s disease (HD) is a rare and fatal disease known as a polyglutamine neurodegenerative disorder effecting only 4-10 per 100,000 people of European decent (Driver-Dunckly et. Al 2007). This means there is a problem with the trinucleotide that codes for glutamine, cytosine-adenine-guanine (CAG). In the case of HD there is an extreme overproduction of the CAG repeats in the protein huntingtin. Accumulation of this mutated form of the protein in neurons causes cell atrophy which in turn causes

Meditation means to concentrate and connect with ones’ own mind, to explore identity and emotions in order to be aware of conscious, sub-conscious and unconscious thoughts. Meditation originates and has been has been practiced in Asia for thousands of years for different reasons such as increasing concentration abilities, religious purposes and also to train the mind. This essay will focus on how meditation affects brain plasticity (ability to change), emotionally and intellectually, leading to better

drugs possess. Cognition enhancing drugs can be used for many different purposes. Many of which can be for legitimate medical purposes ranging from helping to aid people with developmental conditions such as Attention Deficit Hyperactivity Disorder, neurodegenerative

History of Huntington’s Disease Named after George Huntington, Huntington’s Disease is a hereditary neurodegenerative disease. It “causes the death of specific neurons in the brain, leading to jerky movements, physical rigidity, and dementia (First).” The mutation was first mapped to chromosome 4 in 1983, becoming the first disease gene to be mapped using DNA polymorphisms (First). In 1993, a group of investigators found the gene that causes Huntington’s Disease. It is caused by a mutation in a